
Imunon, Inc. (NASDAQ:IMNN) Q1 2025 Earnings Convention Name Could 12, 2025 11:00 AM ET
Firm Individuals
Peter Vozzo – ICR Healthcare, Investor Relations
Stacy Lindborg – President & Chief Govt Officer
Douglas Faller – Chief Medical Officer
David Gaiero – Interim Chief Monetary Officer
Convention Name Individuals
Emily Bodnar – H.C. Wainwright
Laura Suriel – Alliance International Companions
Operator
Good morning. My title is Dave, and I can be your operator as we speak. Presently, I wish to welcome you to Imunon’s First Quarter 20254 Monetary Outcomes Convention Name. All traces have been positioned on mute to stop any background noise. Following the audio system ready remarks; there can be a question-and-answer session. [Operator Instructions]
I’d now like to show the decision over to Peter Vozzo of ICR Healthcare, Investor Relations consultant for Imunon. Please go forward.
Peter Vozzo
Thanks, Dave. Good morning, everybody and welcome to Emunan’s first quarter 2025 monetary outcomes and enterprise replace convention name.
Throughout as we speak’s name, administration can be making forward-looking statements relating to Imunon’s expectations and projections about future occasions. Typically, forward-looking statements will be recognized by phrases, akin to expects, anticipates, believes or different comparable expressions. These statements are primarily based on present expectations and are topic to a lot of dangers and uncertainties, together with these set forth within the firm’s periodic filings with the Securities and Change Fee.
No forward-looking statements will be assured and precise outcomes could differ materially from such statements. I additionally warning that, the content material of this convention name is correct solely as of the date of the stay broadcast, Could 12, 2025. Imunon undertakes no obligation to revise or replace feedback made throughout this name, besides as required by regulation.
With that stated, I wish to flip the decision over to Dr. Stacy Lindborg, President and Chief Govt